Andere Sprachen ADC Therapeutics SA

Aktien

A2PSR8

CH0499880968

ADCT

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 30.04.2024			% 5 Tage	% 1. Jan.
4,41 ^USD	-2,00 %		-11,27 %	+165,66 %

09.04.	Transcript : ADC Therapeutics SA - Special Call
04.04.	Sektor-Update: Aktien des Gesundheitswesens fallen am späten Nachmittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed, Refractory B-cell Non-Hodgkin Lymphoma	05.04.
Sector Update: Health Care Stocks Slump Late Afternoon	04.04.
ADC Therapeutics Shares Rise After Completion of Dose Escalation Part of Phase 1b Lymphoma Trial	04.04.
Borsa svizzera chiude in rialzo, SMI +0,64%	04.04.
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma	04.04.
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024	03.04.
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	01.04.
Chiome Bioscience Cancels License Agreements with ADC Therapeutics	01.04.
ADC Therapeutics SA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	13.03.
ADC Therapeutics SA Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting	06.03.
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit	06.03.
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit	06.03.
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024	06.03.
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting	05.03.
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting	05.03.
ADC Therapeutics : TD Cowen Healthcare Conference	05.03.
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	27.02.
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	27.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ADC Therapeutics SA

Aktien

A2PSR8

CH0499880968

ADCT

Andere Sprachen

Filter